Impact of android overweight or obesity and insulin resistance on basal and postprandial SR-BI and ABCA1-mediated serum cholesterol efflux capacities

Atherosclerosis

Volumn 209, Issue 2, 2010, Pages 422-429

  Attia, Nesrine ^a   Fournier, Natalie ^a   Vedie, Benoît ^b   Cambillau, Michèle ^b   Beaune, Philippe ^b   Ziegler, Olivier ^c   Grynberg, Alain ^a   Paul, Jean Louis ^a,b   Guerci, Bruno ^c  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c Ctr Hospitalier Univ de Nancy   (France)

Author keywords

ABCA1; Android obesity; Cholesterol efflux; Macrophages; Postprandial state; Pre HDL; SR BI

Indexed keywords

ABC TRANSPORTER A1; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPID; SCAVENGER RECEPTOR BI;

ADULT; ANIMAL CELL; ARTICLE; BODY COMPOSITION; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOAM CELL; HEPATOMA CELL; HUMAN; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MACROPHAGE; MOUSE; NONHUMAN; OBESITY; POSTPRANDIAL STATE; PRIORITY JOURNAL; RAT;

ADULT; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BODY COMPOSITION; CARCINOMA, HEPATOCELLULAR; CELL LINE; CHOLESTEROL; FEMALE; FOAM CELLS; HIGH-DENSITY LIPOPROTEINS, PRE-BETA; HUMANS; INSULIN RESISTANCE; LIVER NEOPLASMS; MACROPHAGES; MICE; MIDDLE AGED; OBESITY; OVERWEIGHT; POSTPRANDIAL PERIOD; RATS; SCAVENGER RECEPTORS, CLASS B; TUMOR CELLS, CULTURED; WAIST CIRCUMFERENCE;

EID: 77950021503     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.09.025     Document Type: Article

References (48)

1. Poirier P., Giles T.D., Bray G.A., et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Arterioscler Thromb Vasc Biol 2006, 26:968-976.
2. Reaven G., Abbasi F., McLaughlin T. Obesity, insulin resistance, and cardiovascular disease. Recent Prog Horm Res 2004, 59:207-223.
3. Zhang C., Rexrode K.M., van Dam R.M., Li T.Y., Hu F.B. Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation 2008, 17:1658-1667.
4. Després J.P. Dyslipidemia and obesity. Baillière's Clin Endocrinol Metab 1994, 8:629-660.
5. Lewis G.F., O'Meara N.M., Soltys P.A., et al. Postprandial lipoprotein metabolism in normal and obese subjects: comparison after the vitamin A fat-loading test. J Clin Endocrinol Metab 1990, 71:1041-1050.
6. von Eckardstein A., Nofer J.R., Assmann G. High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport. Arterioscler Thromb Vasc Biol 2001, 21:13-27.
7. Yancey P.G., Bortnick A.E., Kellner-Weibel G., de la Llera-Moya M., Phillips M.C., Rothblat G.H. Importance of different pathways of cellular cholesterol efflux. Arterioscler Thromb Vasc Biol 2003, 23:712-719.
8. Tall A.R. Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins. J Intern Med 2008, 263:256-273.
9. Favari E., Lee M., Calabresi L., et al. Depletion of pre-beta-high density lipoprotein by human chymase impairs ATP-binding cassette transporter A1- but not scavenger receptor class B type I-mediated lipid efflux to high density lipoprotein. J Biol Chem 2004, 279:9930-9936.
10. Fournier N., Paul J.L., Atger V., et al. HDL phospholipid content and composition as a major factor determining cholesterol efflux capacity from Fu5AH cells to human serum. Arterioscler Thromb Vasc Biol 1997, 17:2685-2691.
11. Wang N., Lan D., Chen W., Matsuura F., Tall A.R. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc Natl Acad Sci USA 2004, 101:9974-9979.
12. Gelissen I.C., Harris M., Rye K.A., et al. ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-I. Arterioscler Thromb Vasc Biol 2006, 26:534-540.
13. Mweva S., Paul J.L., Cambillau M., et al. Comparison of different cellular models measuring in vitro the whole human serum cholesterol efflux capacity. Eur J Clin Invest 2006, 36:552-559.
14. Fournier N., Atger V., Cogny A., et al. Analysis of the relationship between triglyceridemia and HDL-phospholipid concentrations: consequences on the efflux capacity of serum in the Fu5AH system. Atherosclerosis 2001, 157:315-323.
15. Fournier N., Francone O., Rothblat G.H., et al. Enhanced efflux of cholesterol from ABCA1-expressing macrophages to serum from type IV hypertriglyceridemic subjects. Atherosclerosis 2003, 171:287-293.
16. Yancey P.G., Asztalos B.F., Stettler N., et al. SR-BI- and ABCA1-mediated cholesterol efflux to serum from patients with Alagille syndrome. J Lipid Res 2004, 45:1724-1732.
17. Attia N., Ramaharo A., Paul J.L., et al. Enhanced removal of cholesterol from macrophage foam cells to serum from type IV hypertriglyceridemic subjects. Atherosclerosis 2008, 198:49-56.
18. Guerci B., Verges B., Durlach V., Hadjadj S., Drouin P., Paul J.L. Relationship between altered postprandial lipemia and insulin resistance in normolipidemic and normoglucose tolerant obese patients. Int J Obes Relat Metab Disord 2000, 24:468-478.
19. Asztalos B.F., Roheim P.S., Milani R.L., et al. Distribution of ApoA-I-containing HDL subpopulations in patients with coronary heart disease. Arterioscler Thromb Vasc Biol 2000, 20:2670-2676.
20. de la Llera Moya M., Atger V., Paul J.L., et al. A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Relations between serum components and efflux, esterification, and transfer. Arterioscler Thromb 1994, 14:1056-1065.
21. Out R., Jessup W., Le Goff W., et al. Coexistence of foam cells and hypocholesterolemia in mice lacking the ABC transporters A1 and G1. Circ Res 2008, 102:113-120.
22. Kobayashi A., Takanezawa Y., Hirata T., et al. Efflux of sphingomyelin, cholesterol, and phosphatidylcholine by ABCG1. J Lipid Res 2006, 47:1791-1802.
23. Sasahara T., Nestel P., Fidge N., Sviridov D. Cholesterol transport between cells and high density lipoprotein subfractions from obese and lean subjects. J Lipid Res 1998, 39:544-554.
24. Autran D., Guerci B., Paul J.L., et al. Basal and postprandial serum-promoted cholesterol efflux in normolipidemic subjects: importance of fat mass distribution. Metabolism 2001, 50:1330-1335.
25. Yancey P.G., Kawashiri M.A., Moore R., et al. In vivo modulation of HDL phospholipid has opposing effects on SR-BI- and ABCA1-mediated cholesterol efflux. J Lipid Res 2004, 45:337-346.
26. Kamel E.G., McNeill G., Van Wijk M.C. Usefulness of anthropometry and DXA in predicting intra-abdominal fat in obese men and women. Obes Res 2000, 8:36-42.
27. Alberti K.G., Zimmet P., Shaw J. IDF epidemiology task force consensus group. The metabolic syndrome: a new worldwide definition. Lancet 2005, 366:1059-1062.
28. Dullaart R.P., van Tol A. Role of phospholipid transfer protein and prebeta-high density lipoproteins in maintaining cholesterol efflux from Fu5AH cells to plasma from insulin-resistant subjects. Scand J Clin Lab Invest 2001, 61:69-74.
29. de Vries R., Groen A.K., Perton F.G., et al. Increased cholesterol efflux from cultured fibroblasts to plasma from hypertriglyceridemic type 2 diabetic patients: roles of pre beta-HDL, phospholipid transfer protein and cholesterol esterification. Atherosclerosis 2008, 196:733-741.
30. Dullaart R.P., Groen A.K., Dallinga-Thie G.M., de Vries R., Sluiter W.J., van Tol A. Fibroblast cholesterol efflux to plasma from metabolic syndrome subjects is not defective despite low high-density lipoprotein cholesterol. Eur J Endocrinol 2008, 158:53-60.
31. Wang X., Collins H.L., Ranalletta M., et al. Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo. J Clin Invest 2007, 117:2216-2224.
32. Boden G. Free fatty acids (FFA), a link between obesity and insulin resistance. Front Biosci 1998, 3:d169-d175.
33. Uehara Y., Miura S., von Eckardstein A., et al. Unsaturated fatty acids suppress the expression of the ATP-binding cassette transporter G1 (ABCG1) and ABCA1 genes via an LXR/RXR responsive element. Atherosclerosis 2007, 191:11-21.
34. Mauldin J.P., Nagelin M.H., Wojcik A.J., et al. Reduced expression of ATP-binding cassette transporter G1 increases cholesterol accumulation in macrophages of patients with type 2 diabetes mellitus. Circulation 2008, 117:2785-2792.
35. Barrans A., Collet X., Barbaras R., et al. Hepatic lipase induces the formation of pre-β1 high density lipoprotein (HDL) from triacylglycerol-rich HDL2. J Biol Chem 1994, 269:11572-11577.
36. Rye K.A., Barter P. Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein A-I. Arterioscler Thromb Vasc Biol 2004, 24:421-428.
37. Syeda F., Senault C., Delplanque B., et al. Postprandial variations in the cholesteryl ester transfer protein activity, phospholipid transfer protein activity and plasma cholesterol efflux capacity in normolipidemic men. Nutr Metab Cardiovasc Dis 2003, 13:28-36.
38. Arai T., Yamashita S., Hirano K., et al. Increased plasma cholesteryl ester transfer protein in obese subjects. A possible mechanism for the reduction of serum HDL cholesterol levels in obesity. Arterioscler Thromb 1994, 14:1129-1136.
39. Riemens S.C., van Tol A., Sluiter W.J., Dullaart R.P. Plasma phospholipid transfer protein activity is related to insulin resistance: impaired acute lowering by insulin in obese type II diabetic patients. Diabetologia 1998, 41:929-934.
40. Dullaart R.P.F., Sluiter W.J., Dikkeschei L.D., Hoogenberg K., Van Tol A. Effect of adiposity on plasma lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism. Eur J Clin Invest 1994, 24:188-194.
41. Jiang X.C., Moulin P., Quinet E., et al. Mammalian adipose tissue and muscle are major sources of lipid transfer protein. J Biol Chem 1991, 266:4631-4639.
42. Kritharides L., Christian A., Stoudt G., Morel D., Rothblat G.H. Cholesterol metabolism and efflux in human THP-1 macrophages. Arterioscler Thromb 1998, 18:1589-1599.
43. Fournier N., Atger V., Paul J.-L., et al. Human apo AIV overexpression in transgenic mice induces cAMP-stimulated cholesterol efflux from J774 macrophages to whole serum. Arterioscler Thromb Vasc Biol 2000, 20:1283-1292.
44. Fournier N., Cogny A., Atger V., et al. Opposite effects of plasma from human apolipoprotein AII transgenic mice on cholesterol efflux from J774 macrophages and Fu5AH hepatoma cells. Arterioscler Thromb Vasc Biol 2002, 22:638-643.
45. Nanjee M.N., Cooke C.J., Wong J.S., Hamilton R.L., Olszewski W.L., Miller N.E. Composition and ultrastructure of size subclasses of normal human peripheral lymph lipoproteins: quantification of cholesterol uptake by HDL in tissue fluids. J Lipid Res 2001, 42:639-648.
46. Adorni M.P., Zimetti F., Billheimer J.T., et al. The roles of different pathways in the release of cholesterol from macrophages. J Lipid Res 2007, 48:2453-2462.
47. Asztalos B.F., Roheim P.S. Presence and formation of " free apolipoprotein AI like" particles in human plasma. Arterioscler Thromb Vasc Biol 1995, 15:1419-1423.
48. McGillicuddy F.C., de la Llera Moya M., Hinkle C.C., et al. Inflammation impairs reverse cholesterol transport in vivo. Circulation 2009, 119:1135-1145.